Overview
Introduction
The problem of patient non-adherence to prescribed drug
regimes has become an issue of increasing importance. Although the current usage
of online compliance tools among consumers is low, a significant proportion
would like to use them in the future. Given the growth potential of eCompliance,
pharmaceutical companies should look for appropriate opportunities to invest in
this channel.
Scope
-
Based on Datamonitors 2004 Consumer Insight Survey,
analyzes the attitudes and preferences of consumers towards the use of
eCompliance tools
-
Explores the different eCompliance channels, along
with key considerations to be made when offering an eCompliance tool
-
Examines the key issues regarding drug compliance
from the patients perspective
-
Outlines opportunities for the pharmaceutical
industry given the potential for growth within the eCompliance market
Report Highlights
The gap between the numbers of patients and physicians
who currently utilize eCompliance tools and those who would highlights the need
for focused campaigns to raise awareness of the tools. Pharmaceutical companies
can ensure access to this untapped part of the market through sponsorship of
education programs and marketing efforts.
Demographic segmentations should be considered when
developing eCompliance tools since patient populations typically differ across
therapy areas. Age, socioeconomic status and place of work are likely to exert
significant influence. To maximize adoption, an eCompliance service should
effectively match the preferences of the targeted patient group.
Reasons to Purchase
-
Assess current unmet patient needs and how online
compliance tools can prospectively address them
-
Understand the impact of non-compliance on the key
stakeholders: healthcare systems, insurance companies, pharmacies,
physicians and patients
-
Identify how demographic differences among target
patient audiences can affect the utility of certain eCompliance channels
View Cart
